In comparison to the placebo group, more participants in the semaglutide group stopped taking the medication due to gastrointestinal problems
C., Gentile, S., Vettor, R
References: Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation - ( GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling - ( Study: Taking GLP-1 drugs may increase risk of key nutrient deficiencies - ( How can GLP-1 drugs affect my skin, hair, and nails
Semaglutide is found in other popular weight loss medications, including Ozempic, but Wegovy contains higher doses
Conversely, protective factors include long-term stable therapy (greater than 3 months) due to tachyphylaxis effects, asymptomatic patients without gastrointestinal complaints, properly timed medication cessation when indicated, and absence of additional gastroparesis risk factors [13]
*Exceeds a 1 mL (100-unit) insulin syringe